Table 3.
Test of association for secondary end points for ABCB1, CYP2C19*2, CYP2C19*17, and PON1
| HR | 95% CI | P | |
|---|---|---|---|
| Stent thrombosis (n = 12) | |||
| ABCB1 | 2.64 | 0.84–8.29 | 0.096 |
| CYP2C19*2 | 2.79 | 0.70–11.16 | 0.147 |
| CYP2C19*17 | 0.27 | 0.04–2.09 | 0.210 |
| PON1 | 0.77 | 0.26–2.22 | 0.622 |
| Revascularization (n = 206) | |||
| ABCB1 | 1.21 | 0.99–1.14 | 0.067 |
| CYP2C19*2 | 1.54 | 1.14–2.07 | 0.004 |
| CYP2C19*17 | 0.86 | 0.66–1.11 | 0.247 |
| PON1 | 0.93 | 0.75–1.14 | 0.470 |
| Myocardial infarction (n = 40) | |||
| ABCB1 | 1.33 | 0.80–2.22 | 0.270 |
| CYP2C19*2 | 2.02 | 0.99–4.12 | 0.054 |
| CYP2C19*17 | 0.63 | 0.31–1.29 | 0.207 |
| PON1 | 1.03 | 0.63–1.69 | 0.906 |
| Death (n = 14) | |||
| ABCB1 | 1.70 | 0.78–3.70 | 0.178 |
| CYP2C19*2 | 1.76 | 0.57–5.37 | 0.323 |
| CYP2C19*17 | 1.62 | 0.69–3.81 | 0.267 |
| PON1 | 0.57 | 0.23–1.44 | 0.231 |
All results report unadjusted Cox proportional hazard models. CI, confidence interval; HR, hazard ratio.